These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 24717917)

  • 21. Development of a physiologically based pharmacokinetic model of 2-methoxyethanol and 2-methoxyacetic acid disposition in pregnant rats.
    Hays SM; Elswick BA; Blumenthal GM; Welsch F; Conolly RB; Gargas ML
    Toxicol Appl Pharmacol; 2000 Feb; 163(1):67-74. PubMed ID: 10662606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism of N-[4-chloro-2-fluoro-5-[(1-methyl-2-propynyl)oxy]phenyl]-3,4,5,6- tetrahydrophthalimide (S-23121) in the rat. II. Absorption, disposition, excretion and biotransformation.
    Yoshino H; Kaneko H; Nakatsuka I; Yamada H
    Xenobiotica; 1993 Oct; 23(10):1075-84. PubMed ID: 8259690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fate of Flumioxazin in Aquatic Plants: Two Algae (Pseudokirchneriella subcapitata, Synechococcus sp.), Duckweed (Lemna sp.), and Water Milfoil (Myriophyllum elatinoides).
    Ando D; Fujisawa T; Katagi T
    J Agric Food Chem; 2017 Oct; 65(40):8813-8822. PubMed ID: 28920683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Degradation of flumioxazin in illuminated water-sediment systems.
    Shibata A; Kodaka R; Fujisawa T; Katagi T
    J Agric Food Chem; 2011 Oct; 59(20):11186-95. PubMed ID: 21919467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a physiologically based pharmacokinetic model for bisphenol A in pregnant mice.
    Kawamoto Y; Matsuyama W; Wada M; Hishikawa J; Chan MP; Nakayama A; Morisawa S
    Toxicol Appl Pharmacol; 2007 Oct; 224(2):182-91. PubMed ID: 17698157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue exposures to free and glucuronidated monobutylyphthalate in the pregnant and fetal rat following exposure to di-n-butylphthalate: evaluation with a PBPK model.
    Clewell RA; Kremer JJ; Williams CC; Campbell JL; Andersen ME; Borghoff SJ
    Toxicol Sci; 2008 Jun; 103(2):241-59. PubMed ID: 18344531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanistic modeling of hepatic transport from cells to whole body: application to napsagatran and fexofenadine.
    Poirier A; Funk C; Scherrmann JM; Lavé T
    Mol Pharm; 2009; 6(6):1716-33. PubMed ID: 19739673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diazabicyclo derivatives as safeners protect cotton from injury caused by flumioxazin.
    Jia L; Zhao LX; Sun F; Peng J; Wang JY; Leng XY; Gao S; Fu Y; Ye F
    Pestic Biochem Physiol; 2022 Oct; 187():105185. PubMed ID: 36127047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of in vitro systems and preclinical data for the prediction of human intestinal first-pass metabolism during drug discovery and preclinical development.
    Karlsson FH; Bouchene S; Hilgendorf C; Dolgos H; Peters SA
    Drug Metab Dispos; 2013 Dec; 41(12):2033-46. PubMed ID: 23918667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A toxicokinetic study of inhaled ethylene glycol ethyl ether acetate and validation of a physiologically based pharmacokinetic model for rat and human.
    Gargas ML; Tyler TR; Sweeney LM; Corley RA; Weitz KK; Mast TJ; Paustenbach DJ; Hays SM
    Toxicol Appl Pharmacol; 2000 May; 165(1):63-73. PubMed ID: 10814554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma concentrations of melengestrol acetate in humans extrapolated from the pharmacokinetics established in in vivo experiments with rats and chimeric mice with humanized liver and physiologically based pharmacokinetic modeling.
    Tsukada A; Suemizu H; Murayama N; Takano R; Shimizu M; Nakamura M; Yamazaki H
    Regul Toxicol Pharmacol; 2013 Apr; 65(3):316-24. PubMed ID: 23395687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A physiologically based pharmacokinetic/pharmacodynamic model for carbofuran in Sprague-Dawley rats using the exposure-related dose estimating model.
    Zhang X; Tsang AM; Okino MS; Power FW; Knaak JB; Harrison LS; Dary CC
    Toxicol Sci; 2007 Dec; 100(2):345-59. PubMed ID: 17804862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study on the residual dynamics of flumioxazin in soybean and soil].
    Lu ZB; Wang Y; Yu P; Liu YL; Xu W
    Se Pu; 2000 Mar; 18(2):145-7. PubMed ID: 12541592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Semi-mechanistic physiologically-based pharmacokinetic modeling of clinical glibenclamide pharmacokinetics and drug-drug-interactions.
    Greupink R; Schreurs M; Benne MS; Huisman MT; Russel FG
    Eur J Pharm Sci; 2013 Aug; 49(5):819-28. PubMed ID: 23806476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiologically based pharmacokinetic modeling of cyclotrimethylenetrinitramine in male rats.
    Krishnan K; Crouse LC; Bazar MA; Major MA; Reddy G
    J Appl Toxicol; 2009 Oct; 29(7):629-37. PubMed ID: 19629953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo and in vitro studies of perchloroethylene metabolism for physiologically based pharmacokinetic modeling in rats, mice, and humans.
    Reitz RH; Gargas ML; Mendrala AL; Schumann AM
    Toxicol Appl Pharmacol; 1996 Feb; 136(2):289-306. PubMed ID: 8619237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical and clinical pharmacokinetics of PF-02413873, a nonsteroidal progesterone receptor antagonist.
    Bungay PJ; Tweedy S; Howe DC; Gibson KR; Jones HM; Mount NM
    Drug Metab Dispos; 2011 Aug; 39(8):1396-405. PubMed ID: 21543556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of human relevance for rat developmental toxicity of flumioxazin is revealed by comparative heme synthesis assay using embryonic erythroid cells derived from human and rat pluripotent stem cells.
    Asano K; Takahashi Y; Ueno M; Fukuda T; Otani M; Kitamoto S; Tomigahara Y
    J Toxicol Sci; 2022; 47(4):125-138. PubMed ID: 35370240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A physiologically based pharmacokinetic (PB-PK) model for 1,2-dichlorobenzene linked to two possible parameters of toxicity.
    Hissink AM; Van Ommen B; Krüse J; Van Bladeren PJ
    Toxicol Appl Pharmacol; 1997 Aug; 145(2):301-10. PubMed ID: 9266803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.